The Boston Scientific ACCESS Trial

Summary

The Boston Scientific ACCESS Trial is a clinical trial^[1].

Key Facts

• The Boston Scientific ACCESS Trial is in the country of United States^[2].
• The Boston Scientific ACCESS Trial's instance of is recorded as clinical trial^[3].
• The Boston Scientific ACCESS Trial's start time is recorded as +2005-12-31T00:00:00Z^[4].
• The Boston Scientific ACCESS Trial's end time is recorded as +2007-05-31T00:00:00Z^[5].
• The Boston Scientific ACCESS Trial's number of participants is recorded as {'unit': '1', 'amount': '+149'}^[6].
• The Boston Scientific ACCESS Trial's title is recorded as ACCESS: Prospective, Multi-center Trial of the Fusion Vascular Access Graft for Patients Who Require Early Vascular Access for Hemodialysis^[7].
• The Boston Scientific ACCESS Trial's short name is recorded as ACCESS^[8].
• The Boston Scientific ACCESS Trial's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[9].
• The Boston Scientific ACCESS Trial's ClinicalTrials.gov ID is recorded as NCT00260728^[10].
• The Boston Scientific ACCESS Trial's clinical trial phase is recorded as phase II clinical trial^[11].
• The Boston Scientific ACCESS Trial's clinical trial phase is recorded as phase III clinical trial^[12].
• The Boston Scientific ACCESS Trial's research site is recorded as Rush University Medical Center^[13].
• The Boston Scientific ACCESS Trial's research site is recorded as Beth Israel Deaconess Medical Center^[14].
• The Boston Scientific ACCESS Trial's research site is recorded as Cleveland Clinic^[15].
• The Boston Scientific ACCESS Trial's study type is recorded as interventional study^[16].